MedPath

Psychotherapy for Intermittent Explosive Disorder

Not Applicable
Completed
Conditions
Anger
Intermittent Explosive Disorder
Interventions
Behavioral: Cognitive Behavioral Therapy
Behavioral: Supportive Psychotherapy
Registration Number
NCT00667212
Lead Sponsor
University of Chicago
Brief Summary

The goal of this study is to examine the effectiveness two forms of psychotherapy (also known as "talk therapy" ) for individuals with anger and aggression problems. Anger and aggression are everywhere - on the road, in the schools, at little league games, at home, and at work. In this study we are testing usefulness of anger management techniques in reducing symptoms of Intermittent Explosive Disorder (IED) and impulsive, aggressive behavior.

Detailed Description

Qualified participants will be randomly assigned to 12 1-hour sessions of either cognitive-behavioral therapy or supportive psychotherapy.

Participation in this study will require 13 visits over approximately 4 months with a 3 follow-up session. Therapy is provided at no cost and each study participant will receive a comprehensive psychological assessment. Two types of talk therapy are being offered in this study. One form of therapy focuses on thought and behaviors associated with anger and aggression. This type of therapy is known as cognitive behavioral therapy. The other type of therapy focuses on the individuals' feeling about their anger /aggression and the situations that lead to this anger. This is known as supportive therapy. The form of therapy you are given will be randomly determined (like by flipping of a coin).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Have problems with anger, temper outbursts, being irritable, getting in trouble at work or at home because of impulsive/aggressive behavior.
  • Between the ages of 18 and 55.
  • Meet other eligibility requirements as outlined by the research protocol.
Exclusion Criteria
  • Lifetime diagnosis of psychosis or bipolar disorder
  • Current diagnosis of substance dependence or major depressive disorder.
  • Current suicidal or homicidal ideation,
  • Recent use of selective serotonin reuptake inhibitors (past month) or other psychotropic medication (past two months)
  • Recent psychotherapy for aggression (past six months.)

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
1Cognitive Behavioral TherapyCognitive Behavioral Therapy (Cognitive Restructuring, Relaxation, and Coping Skills Training: CRCST)
2Supportive PsychotherapySupportive Psychotherapy
Primary Outcome Measures
NameTimeMethod
Change in Hostile Automatic Thoughts (HAT) ScaleUp to 12 months

Each item is answered on a 5-point Likert scale ranging from 0=not at all to 5=all the time. Higher scores indicate higher frequency of hostile thoughts experienced.

Change in Overt Aggression Scale - Modified (OASM) ScoreUp to 12 months

Items are scored on a 5-point scale. Higher scores indicate higher levels of aggression.

Change in State-Trait Anger Expression Inventory - Trait Anger Scale [STAXI-2]Up to 12 months

Items are scored on a 4-point scale. Higher scores indicate high levels of anger.

Secondary Outcome Measures
NameTimeMethod
Change in Self-Report of Aggression and Social Behavior Measure (SRASBM) ScoreUp to 12 months

Items are scored on a 7-point scale to indicate how truthfully the statement describes personal experiences during the past year, ranging from 0=not at all true to 7=very true. Higher scores indicate high levels of aggression

Change in Social Information Processing-Attribution and Emotional Response Questionnaire (SIP-AEQ) ScoreUp to 12 months

Items are scored on a 0-3 Likert scale (0 = not at all likely to 3 = extremely likely). Higher scores indicate higher levels of hostility.

Trial Locations

Locations (1)

University of Chicago

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath